Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used throughout the world.
1. Oral challenge testing with aspirin  Introduction
Controlled oral challenge test is the main tool for diagnosis, and it is also the only unanimously accepted diagnostic method that makes it possible to identify patients with exclusively cutaneous symptoms [34] .
 Indications
The indications are well established: for confirming or ruling out a diagnosis of hypersensitivity to the culprit drug in patients for whom there are no other conclusive allergology tests; and challenge with a drug other than that which produced the reaction, generally aspirin, in order to confirm or rule out cross-reactivity between NSAIDs [34] .
Additional indications include the following [34, 35] : a) Providing a safe alternative therapy in cases of confirmed hypersensitivity. J Investig Allergol Clin Immunol 2020; Vol. 30 (5) © 2019 Esmon Publicidad doi: 10.18176/jiaci.0449 11 b) The need to perform desensitization to aspirin for therapeutic purposes.
c) The study of real prevalence of sensitization to aspirin. d) Investigation of the underlying basic pathogenic mechanisms in this type of reaction.
Despite these indications, performance of controlled provocation tests is highly controversial. Some authors recommend them, whereas others do not, since they believe that the risk of triggering severe anaphylactic reactions is high. Therefore, it seems reasonable to evaluate the individual patient carefully before performing an oral provocation test [35, 36] .
 Contraindications
The main contraindications are as follows [34, 36] health professionals and at centers with the necessary equipment to treat severe systemic reactions [33, 34, [37] [38] [39] . The patient must sign a written informed consent document before undergoing the test [33, 39, 40] and must be stable, with well-controlled asthma [baseline FEV 1 must be at least 60-70% of predicted and more than 1.5 L (absolute) [33, 34] . It has been suggested that LT receptor antagonists, corticosteroids [inhaled and oral], long-acting beta-agonists (LABA) and long-acting muscarinic antagonists reduce the risk of bronchospasm in oral and bronchial provocation testing without altering naso-ocular reactions [41] [42] [43] [44] .
Even mores, new evidence shows that Omalizumab reduces or eliminates aspirin intolerance in treated patients [45, 46] . Although not published so far, new biologicals targeting anti IL-5/IL-5 receptor might also modify the results of aspirin challenge [47] , so we consider that aspirin challenges should not be performed, or well carefully interpreted in patients receiving biologicalsIn sum, and in line with current European guidelines, this document recommends avoiding some drugs before performing the tests [36, 48] (see also [43, 54] .
An oral provocation test is defined as negative when the maximum cumulative dose of aspirin is reached without signs, symptoms, or reaction and with no decrease in FEV 1 >20% over baseline. intravenous antihistamines H 2 [54] . Anaphylactic reactions must be managed with intramuscular epinephrine and according to the protocol recommended by current guidelines [54, [56] [57] [58] .
 Special situations:
o Pediatric patients: NSAIDs are the most commonly prescribed drugs in pediatric medicine, whether as antipyretic, anti-inflammatory, or analgesic agents.
Therefore, it is necessary to make the correct diagnosis in the case of suspected hypersensitivity reaction. Diagnosis in children is complex, since childhood fever is caused by both bacterial and viral infections, which can progress with cutaneous symptoms that mimic an allergic reaction. A study performed in Spain showed that specific nonimmunological reactions are the most common in children. Ibuprofen is the most frequently involved drug, angioedema the most frequently reported condition, and controlled oral provocation the most reliable diagnostic method [59] . In pediatric patients, prescription of authorized drugs is limited by the patient's age. Paracetamol is the preferred oral antipyretic agent, As is the case in adults, diagnostic algorithms based solely on the clinical history have low positive and negative predictive values, are of little worth, and can never replace an allergology work-up consisting of skin tests (when a selective reaction is suspected) and controlled oral provocation, which is considered the gold standard [62] .
Indications and contraindications, as well as the methodology and techniques used in controlled oral provocation test in adults, can almost be generalized to children, with some slight variations. As in adults, there are several protocols, which differ in the following respects:
Oral provocation testing has been compared with bronchial provocation testing in 3 studies [71, 72, 73] . The results reported were similar. Both methods have the same specificity (around 93%), although oral provocation is more sensitive (89% vs 77%) [71] . Therefore, as the negative predictive value of bronchial testing is lower, a negative result should be followed by an oral provocation test in order to obtain the definitive diagnosis [33] .
 Indications
Patients over18 years with suspicion of NERD who present with bronchial symptoms after taking NSAIDs.
 Contraindications
The contraindications are basically those of spirometry itself (eg. recent surgery, aneurisms, etc.) as well as severe or poorly controlled asthma during the previous month, severe diseases (heart, digestive, liver, or kidney), respiratory infection during the 4 weeks before the provocation test, pregnancy, and treatment with betablockers. Table 1 ).
o Procedure: Bronchial provocation is performed with lysine-aspirin, a salt of aspirin that is more water-soluble than aspirin (40% vs 0.3%), less irritant, and better tolerated for inhalation. The technique was first described by Bianco The test is started with baseline spirometry to verify that FEV 1 is >70% predicted and >1.5 L. The test cannot be performed if this requirement is not fulfilled.
The patient first receives 5 inhalations of the control diluent (physiologic saline 0.9%). Spirometry is repeated at 10 minutes. A decrease of >10% in FEV 1 is considered a sign of airway instability that could generate a false-positive result; therefore, the test should be postponed. If FEV 1 does not decrease by more than 10% over baseline, the test continues and the FEV 1 recorded with the diluent is the reference value. 
Nasal challenge with lysine-aspirin  Introduction
While a large number of studies have addressed the standardization of oral and bronchial provocation testing with aspirin, fewer studies have analyzed nasal provocation, despite the fact that it is a safe alternative to oral provocation and bronchial provocation in the assessment of patients with hypersensitivity to NSAIDs.
Nasal provocation testing was implemented in daily clinical practice at the end of the 1970s and 1990s, both for challenges with allergens/drugs and for the study of the response to treatment, as well as for study of the immunology and pathophysiology of the nasal mucosa. Guidelines and consensus statements on the methodology and diagnostic use of nasal provocation have been published [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] . The diagnostic usefulness of nasal provocation and bronchial provocation compared with oral provocation is summarized in Table 4 .
The nasal provocation test involves reproducing a response in the nasal mucosa with controlled exposure to the drug [using lysine-aspirin, as in bronchial provocation]. The response is characterized by nasal obstruction, rhinorrhea, and edema of the nasal mucosa, with increased airflow resistance. Airflow resistance can be measured objectively using 2 techniques: rhinomanometry (RNM) and acoustic rhinometry (ARM) (see below). In addition, the patient's symptoms can be evaluated subjectively during nasal challenge using a visual analog scale and symptom scores (rhinorrhea, sneezing, nasal obstruction and pruritus).
One of the main limitations of this diagnostic method results from its low sensitivity and, therefore, its low negative predictive value. Therefore, a history that is suggestive of NERD and a negative result in a nasal provocation test with lysine-aspirin still require confirmatory oral provocation.
However, if we consider the yield of this approach and its ability to identify conjunctival symptoms, it should be considered the method of choice in patients who report analgesic-induced nasal-ocular symptoms.
 Indications
Nasal provocation is indicated in the study of patients with suspected NERD and, more specifically, in those whose concomitant conditions prevent them from undergoing oral or bronchial provocation as for instance in patients with FEV 1 <70% (see above).
 Contraindications
Nasal provocation should not be performed in the following cases: -The patient must be asymptomatic, that is, if the patient also has another type of rhinitis such as allergic or infectious rhinitis, then the test should be performed outside the pollen season or, in the case of perennial allergens, when mild symptoms do not interfere with the results of the test. The test should be postponed until at least 2-4 weeks after an exacerbation of allergic or infectious rhinitis [82, 84, 85] .
-The patient must also be free of respiratory symptoms, with no asthma exacerbations or bronchial infections in the last month at the time of the test. Forced spirometry is always recommended before and after nasal provocation in order to evaluate lung function.
-The patient should avoid smoking and alcohol during the 24-48 hours before the test.
-The provocation should be postponed for 6-8 weeks after nasal surgery [84] .
-Where possible, avoid performing nasal provocation during pregnancy.
-Nasal provocation is not recommended in patients with a perforated septum or total nasal obstruction, since objective evaluation of nasal obstruction is very difficult and interpretation of the results more complicated.
-Any medication that can modify the nasal response must be discontinued before the test (see Table 1 ).
ii. Room-related conditions -Temperature and humidity must be maintained at a constant temperature of 20ºC to 22ºC with humidity of 40%-60%. Temperatures above 35ºC with a high degree of humidity (80%-90%) can alter the immediate response owing to diminished release of histamine and the vascular/neural response [90] .
-The patient must be acclimated (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) 
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-Nasal challenge should preferably be performed in the morning in order to avoid the irritant effect of the usual daily stimulants (eg, tobacco smoke, pollution, spicy food, coffee, exercise).
iii. Conditions related to the staff who carry out the test -Appropriate knowledge of the test methodology.
-Appropriate knowledge of the technique that will be used to evaluate the results, eg, RNM or ARM. The most widely used approach today is instillation of 0.1 mL of lysine-aspirin at the head of the inferior turbinate with a syringe, pipette, or dropper. Lysineaspirin is not available in the USA, where nasal provocation is performed using intranasal ketorolac [33, 91] . In addition, there is also experience using ketorolac in the group of Quiralte-Castillo et al. [92] A micropipette is preferred. Doses of lysine-aspirin vary according to the author and are detailed below.
Objective evaluation is usually by active anterior RNM (AARNM) or ARM. RNM enables simultaneous measurement of flow and pressure variations in air current crossing the nostrils during the different phases of respiration. For evaluation of nasal permeability, AARNM with a facemask and computerized recording of pressure, flow and resistance is recommended as the optimal test in daily clinical practice [93, 94] .
The doses of lysine-aspirin used in nasal provocation with AARNM vary according to the protocol: 20 mg as the maximum cumulative aspirin-equivalent dose [ ARM is used to evaluate nasal permeability through measurement of areas and volumes in the nasal cavity based on reflection of sound waves through an acoustic rhinometer. It is noninvasive and reproducible and requires only minimal cooperation from the patient. Therefore, it is easy to use with children.
It is well standardized for the demonstration of changes in the permeability of the nasal mucosa.
Measurements are made at different time points depending on the method used [33, 98] . Therefore, we must perform a measurement at baseline, 30 minutes after administration of the diluent, and at 15, 30, 60, and 90 minutes after administration of lysine-aspirin. Diluent (0.9% NaCl) is administered beforehand in order to rule out nasal hyperreactivity. We then administer 29 mg of lysineaspirin 100 µL [equivalent to 16 mg of aspirin] to the inferior turbinate of each nostril using an Eppendorf pipette [99, 100] .
 Interpretation
Nasal provocation with lysine-aspirin performed using ARM is considered positive when nasal cavity volume at 12 cm decreases by 25% with respect to the postdiluent value [98, 99] . Some studies show that the test can be considered positive when there is a fall of 25% in nasal volume at 2-5 cm [99, 100] . Values obtained using ARM should also be correlated with clinical symptoms [subjective values] by means of the visual analog scale [see above] and symptom scores. A positive result is defined as an increase of 30% of airflow resistance [90, 99, 101] .
The reference values obtained using AARNM are not fully agreed upon, and a certain degree of variability is accepted as a result of differences in the devices used, age, *If the patient has a history of attending the emergency department for asthma and/or baseline FEV 1 the first test should be with the lowest dose possible of aspirin (20 or 30 mg). ** If the patient has a history of serious reactions to NSAIDs, the protocol should be started with 20 mg 60 minutes before the dose of 40 mg. *** If the patient has a history of severe reaction to ASA or other NSAIDs, divide the first dose of aspirin (27 mg) into 2 doses (10 mg and 17 mg), which should be administered at an interval of 90-120 minutes. 
